An antibody therapy could prolong the effect of medication designed to treat methamphetamine addiction, a study in mice suggests.
There is currently no medication approved by the Food and Drug Administration for methamphetamine addiction. Scientists are developing promising treatments that trigger an immune system response, the Los Angeles Times reports.
If a daily anti-addiction medication is developed for meth, it will face a major challenge, according to the newspaper. The urge to use meth can easily overwhelm the desire to quit, making it likely the person will discontinue the medication and continue using meth.